Literature DB >> 1247858

Deficiency of factor B of the complement system in sickle cell anaemia.

W A Wilson, G R Hughes, P J Lachmann.   

Abstract

Factors B and D as well as the total activity of the alternative pathway of complement activation were measured using a functional assay in sera from 29 patients with sickle cell anaemia and 18 normal controls. Total alternative pathway activity was reduced in the patients compared with controls. In patients with abnormally low total alternative pathway activity factor D levels were normal, whereas factor B levels were significantly depressed to a mean level of about half of normal. Regression analysis in patients also showed a significant relation between total alternative pathway activity and factor B levels. A deficiency of factor B is the likely cause of the defect in the complement system in patients with sickle cell anaemia. Such a defect may contribute to the excessive proneness of such patients to severe infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247858      PMCID: PMC1638784          DOI: 10.1136/bmj.1.6006.367

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

Authors:  P A Nicol; P J Lachmann
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

3.  Functional relationship of factor B in the properdin system to C3 proactivator of human serum.

Authors:  I Goodkofsky; I H Lepow
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

4.  Treatment and prevention of sickle-cell crisis.

Authors: 
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

5.  An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors:  R B Johnston; S L Newman; A G Struth
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

6.  Pneumococcal meningitis in sickle-cell anemia.

Authors:  M G Robinson; R J Watson
Journal:  N Engl J Med       Date:  1966-05-05       Impact factor: 91.245

7.  Abnormal distribution of haemoglobin genotypes in Negro children with severe bacterial infections.

Authors:  R Eeckels; F Gatti; A M Renoirte
Journal:  Nature       Date:  1967-10-28       Impact factor: 49.962

8.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

9.  Properdin factor D: characterization of its active site and isolation of the precursor form.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  13 in total

1.  Systemic lupus erythematosus and sickle-cell anaemia.

Authors:  W A Wilson; G D Nicholson; G R Hughes; S Amin; G Alleyne; G R Serjeant
Journal:  Br Med J       Date:  1976-04-03

2.  Complement activation in asymptomatic patients with sickle cell anaemia.

Authors:  W A Wilson; E J Thomas; J G Sissons
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

3.  Hemoglobin sickle cell disease and systemic lupus erythematosus.

Authors:  R P Warrier; S Sahney; H Walker
Journal:  J Natl Med Assoc       Date:  1984-10       Impact factor: 1.798

4.  Nature of complement deficiency in sickle cell disease.

Authors:  W A Wilson
Journal:  Arch Dis Child       Date:  1983-03       Impact factor: 3.791

5.  Immunologic defect of the alternate pathway-of-complement activation postsplenectomy: a possible relation between splenectomy and infection.

Authors:  A de Ciutiis; M J Polley; L J Metakis; C M Peterson
Journal:  J Natl Med Assoc       Date:  1978-09       Impact factor: 1.798

6.  Recurrent meningitis in a child with combined IgA deficiency and splenic hypoplasia.

Authors:  C J Taylor
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

7.  Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.

Authors:  A Nowak-Wegrzyn; J A Winkelstein; A J Swift; H M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

8.  Activation of the alternative pathway of human complement by haemoglobin.

Authors:  W A Wilson; E J Thomas
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

9.  Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.

Authors:  A B Bjornson; J S Lobel; P I Magnafichi; B C Lampkin
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

10.  Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.

Authors:  V F Larcher; R J Wyke; L R Davis; C E Stroud; R Williams
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.